「research」の検索結果
87件：61～65件目を表示
-
Mytear EYETECT ALPITATTO | OTC Products, etc. | Products | SENJU Pharmaceutical
This medicine is recommended for people who have continuing allergy symptoms with inflammation. Category 2 OTC medicines Mytear® EYETECT® ALPITATTO Works on unpleasant eye itching due to pollens and o
https://www.senju.co.jp/english/products/ap.html -
お知らせ | 千寿製薬株式会社
December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation chann
https://www.senju.co.jp/english/news/ -
Mytear EYETECT | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 2 OTC medicines Mytear® EYETECT® For teary eye, foreign body sensation CHARACTERISTICS Mytear EYETECT includes the anti-inflammatory ingredient, pranoprofen [swich OTC Drug], and is effective
https://www.senju.co.jp/english/products/eyetect.html -
Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
Communications with Customers and Provision of Information to Senju Pharmaceutical has a Customer Service Center for directly responding to inquiries from consumers and patients. The role of the Cente
https://www.senju.co.jp/english/about/csr01.html -
千寿製薬株式会社
NEWS & RELEASE December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Pot
http://www.senju.co.jp/english/